glipizide and vildagliptin

glipizide has been researched along with vildagliptin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bloomgarden, ZT; Inzucchi, SE1
Han, X; Ji, L; Li, J; Li, Y; Qiu, L; Ren, H; Shi, Z; Wu, K; Yang, F; Zhang, X; Zhao, C; Zhong, H; Zhou, X1

Trials

1 trial(s) available for glipizide and vildagliptin

ArticleYear
Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial.
    Diabetologia, 2022, Volume: 65, Issue:10

    Topics: Acarbose; Blood Glucose; China; Diabetes Mellitus, Type 2; Ecosystem; Gastrointestinal Microbiome; Gastrointestinal Tract; Glipizide; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; Research; Vildagliptin

2022

Other Studies

2 other study(ies) available for glipizide and vildagliptin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
New treatments for diabetes.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Adamantane; Adenosine Deaminase Inhibitors; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glipizide; Glycated Hemoglobin; Glycoproteins; Humans; Hypoglycemic Agents; Nitriles; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Vildagliptin

2007